online ISSN 2415-3176
print ISSN 1609-6371
logoExperimental and Clinical Physiology and Biochemistry
J. 2024, 101(3): 71–80
https://doi.org/10.25040/ecpb2024.03-04.071

Experimental medicine


The impact of protein-salt hyperosmolar solution on hemostasis in experimental animal study

B. O. KONDRATSKYI¹ , V. V. KRASIVSKA¹ , YA. B. KONDRATSKYI² , D. L. KACHMARYK¹ , M. Yo. VYNARCHYK¹ , O. M. PANAS¹ , V. L. NOVAK¹ , V. V. ORLYK3

Received: 26-07-2024

Accepted: 22-01-2025

Published: 04-02-2025

Abstract

Abstract. Experimental and clinical findings regarding hypocoagulation induced by various colloid substances, hypertonic crystalloids, and polyatomic alcohols in the literature are conflicting due to variations in doses and physicochemical properties of specific solutions across different studies.

Aim. To investigate the mediated effect of a multicomponent protein-salt hyperosmolar solution on hemostasis in an experimental study on white rats.

Methods. The protein-salt hyperosmolar solution under the laboratory code AXAM was studied, composed of 5 % donor albumin, xylitol, sodium acetate, malate, and electrolytes Na+, K+, Ca++, Mg++, and Cl–; the theoretical osmolarity of the solution was approximately 640 mOsm/L. The study was conducted on male white rats divided into experimental and control groups, each consisting of 10 animals. The experimental group received intra-abdominal injections of AXAM at a dose of 10 ml/kg daily for 30 days. No manipulations were performed on the control group. Blood samples were collected from the animals at the end of the study for analysis. Screening coagulation tests and thromboelastography (TEG) were conducted for a comprehensive assessment of the hemostatic system.

Results. No statistically significant differences were observed in the indicators of screening coagulation tests between the experimental and control groups (p > 0.05). The analysis of parameters utilizing the comprehensive hemostasis assessment method, thromboelastography (TEG), revealed that fundamental parameters such as reaction time (R), clotting time (K), α-Angle, maximum amplitude (MA), and coagulation index (CI) in both the control and experimental groups did not exhibit statistically significant variations (p > 0.05). Furthermore, there were no discernible distinctions between the groups (p > 0.05) in the value of G, indicative of clot density and quality. Notably, clot lysis within 30 minutes was not observed in either group of animals.

Conclusion. The repeated intraperitoneal administration of the proteinsalt hyperosmolar solution AXAM at a dose of 10 ml/kg daily for 30 days does not elicit statistically significant changes (p > 0.05) in the blood coagulation system in experimental rats.

Keywords: albumin, hyperosmolar solutions, protein-salt infusion preparations, hemostasis, thromboelastography

Full text: PDF (Ukr)

References
  1. Yozova ID, Howard J, Henke D, Dirkmann D, Adamik KN. Comparison of the effects of 7.2 % hypertonic saline and 20 % mannitol on whole blood coagulation and platelet function in dogs with suspected intracranial hypertension - a pilot study. BMC Vet Res. 2017;13:185. Published online 2017 Jun 19.doi.org/10.1186/s12917-017-1108-2
  2. Adamik KN, Butty E, Howard J. In vitro effects of 3 % hypertonic saline and 20 % mannitol on canine whole blood coagulation and platelet function. BMC Vet Res. 2015;242(11).doi.org/10.1186/s12917-015-0555-x
  3. Boyd CJ, Brainard BM, Smart L. Intravenous Fluid Administration and the Coagulation System. Front Vet Sci.; 2021 Apr 15;8:662504.doi.org/10.3389/fvets.2021.662504
  4. Chan A, Hughes D, Brett S, Tennent-Brown BS, Boller M. In vitro effects of lactated Ringer's solution, hypertonic saline, hydroxyethyl starch, hypertonic saline/hydroxyethyl starch, and mannitol on thromboelastographic variables of canine whole blood. Journal of Veterinary Emergency and Critical Care. May/June 2020;30(3):255-63.doi.org/10.1111/vec.12929
  5. Coleman JR, Moore EE., Silliman ChC, Stettler GR, Nunns GR, Samuels JM, et al. Examining the Effect of Hypertonic Saline Administered for Reduction of Intracranial Hypertension on Coagulation. Journal of the American College of Surgeons: March 2020; 230(3):322-330e2.doi.org/10.1016/j.jamcollsurg.2019.11.011
  6. Borrelli A, Giunti M, Calipa S, Botto A, Mengozzi G, Lisa G, Maurella C, Bruno B. Assessment of hemostasis in dogs with gastric-dilation-volvulus, during resuscitation with hydroxyethyl starch (130/0.4) or hypertonic saline (7.5 %). J Vet Emerg Crit Care (San Antonio).2021 Nov;31(6):698-707.doi.org/10.1111/vec.13148
  7. Ziebart A., Ruemmler R, Möllmann Ch, Kamuf J., Garcia-Bardon A., Thal SC, Hartmann EK. Fluid resuscitation-related coagulation impairment in a porcine hemorrhagic shock model. PeerJ. 2020 Feb 10:8:e8399.doi.org/10.7717/peerj.8399
  8. Iannucci C, Dirkmann D, Howard J, Adamik KN. A prospective randomized open-label trial on the comparative effects of 6 % hydroxyethyl starch 130/0.4 versus polyionic isotonic crystalloids on coagulation parameters in dogs with spontaneous hemoperitoneum. J Vet Emerg Crit Care (San Antonio). 2021 Jan;31(1):32-42.doi.org/10.1111/vec.13018
  9. Barbu M, Kolsrud O, Radulovic V, et al. Hemostatic effects of a dextran-based priming solution for cardiopulmonary bypass: A secondary analysis of a randomized clinical trial. Thromb Res. 2023;223(August 2022):139-145.doi.org/10.1016/j.thromres.2023.01.028
  10. Mohamed AA, Elsharkawi NG, Zaid OI, Mohamed AF, Mohamed NN, Wadeed MW, et al. Comparison of the Effects of Albumin 5 % versus Ringer's Lactate on Blood Loss and Coagulation after Vascular Surgery Using Thromboelastography. Open Access Maced J Med Sci.2019 Apr 30;7(8):1335-41. Published online 2019 Apr 29.doi.org/10.3889/oamjms.2019.263
  11. Wohlauer MV, Moore EE, Harr J, Gonzalez E, Fragoso M, Silliman CC. A Standardized Technique for Performing Thrombelastography in Rodents Shock. 2011 Nov;36(5):524-26.doi.org/10.1097/SHK.0b013e31822dc518
  12. Hofer S, Ay C, Rejtö J, Wolberg A, Haslacher H, Koder S, Gebhart J, et al. Thrombin generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause. J Thromb Haemost. 2019 Sep; 17(9): 1478-1488. Published online 2019 Jul15.doi.org/10.1111/jth.14529
  13. Lancé MD. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thrombosis J. 2015 Jan;12(13):1-6.doi.org/10.1186/1477-9560-13-1
  14. Schmidt AE, Israel AK, Refaai MA. The Utility of Thromboelastography to Guide Blood Product Transfusion. Am J Clin Pathol. 2019 Sep 9;152(4):407-422.doi.org/10.1093/ajcp/aqz074
  15. Carter KT, Palei AC, Spradley FT, Witcher BM, Martin L, Hester RL, Kutcher ME. A rat model of orthopedic injury-induced hypercoagulability and fibrinolytic shutdown. J Trauma Acute Care Surg. 2020 Nov;89(5):926-931.doi.org/10.1097/TA.0000000000002924
  16. Bassan T, Pastor J, Agulla B, Jornet O, Martorell J. Reference Range of Kaolin-Activated Thromboelastography (TEG) Values in Healthy Pet Rabbits (Oryctolagus cuniculus). Animals (Basel). 2023 Jul 23;13(14):2389.doi.org/10.3390/ani13142389
  17. Herrero Y, Schefer RJ, Muri BM, Sigrist NE. Serial Evaluation of Haemostasis Following Acute Trauma Using Rotational Thromboelastometry in Dogs. Vet Comp Orthop Traumatol. 2021 May;34(3):206-213.doi.org/10.1055/s-0040-1719167
  18. Hennink I, Peters L, van Geest G, Adamik KN. Evaluation of a Viscoelastic Coagulation Monitoring System (VCM Vet®) and Its Correlation with Thromboelastometry (ROTEM®) in Diseased and Healthy Dogs. Animals (Basel). 2023 Jan 25;13(3):405.doi.org/10.3390/ani13030405
  19. Verma A, Hemlata. Thromboelastography as a novel viscoelastic method for hemostasis monitoring: Its methodology, applications, and constraints. Global Journal of Transfusion Medicine. 2017 Jan.;2(1):8-18.doi.org/10.4103/GJTM.GJTM_4_17
  20. Mayerhöfer T., Wiedermann C.J, Joannidis M. Use of albumin: State of the art Einsatz von Albumin: State of the art. Medizinische Klin - Intensivmed und Notfallmedizin.2021;116(8):655-64.doi.org/10.1007/s00063-021-00875-4
  21. Wigmore GJ, Anstey JR, St. John A, Greaney J, Morales-Codina M, Presneill JJ, et al. 20 % Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study). J Cardiothorac Vasc Anesth. 2019;33(11):2920-7.doi.org/10.1053/j.jvca.2019.03.049
  22. Skubas NJ, Callum J, Bathla A, et al. Intravenous albumin in cardiac and vascular surgery: a systematic review and meta-analysis. Br J Anaesth. 2023;(July).doi.org/10.1016/j.bja.2023.11.009
  23. Macedo E, Karl B, Lee E, Mehta RL. A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients. Crit Care. 2021 Jan 6;25(1):18.doi.org/10.1186/s13054-020-03441-0
  24. Löffel LM, Hahn RG, Engel D, Wuethrich PY. Intraoperative Intravascular Effect of Lactated Ringer's Solution and Hyperoncotic Albumin during Hemorrhage in Cystectomy Patients. Anesth Analg. 2021 Aug 1;133(2):413-22.doi.org/10.1213/ANE.0000000000005173
  25. Mårtensson J, Bihari S, Bannard-Smith J, Glassford NJ, Lloyd-Donald P, Cioccari L, et al. Small volume resuscitation with 20% albumin in intensive care: physiological effects:the SWIPE randomised clinical trial. Intensive Care Med. 2018;44:1797-1806.doi.org/10.1007/s00134-018-5253-2
  26. Wiedermann CJ. Moderator Effect of Hypoalbuminemia in Volume Resuscitation and Plasma Expansion with Intravenous Albumin Solution. Int J Mol Sci. 2022;23(22).doi.org/10.3390/ijms232214175
  27. Liu P, Zhi D, Wang Y, Lin J, Zhang M, Duan M. Effects of Albumin Supplements on In-Hospital Mortality in Patients with Sepsis or Septic Shock: A Systemic Review and Meta-Analysis. Evidence-based Complement Altern Med. 2022 Oct 10:2022:2384730.doi.org/10.1155/2022/2384730
  28. Caraceni P, O'Brien A, Gines P. Long-term albumin treatment in patients with cirrhosis and ascites. J Hepatol. 2022;76(6):1306-1317.doi.org/10.1016/j.jhep.2022.03.005
  29. Kitchen S, McCraw A, Echenagucia M. Diagnosis of haemophilia and other bleeding disorders: A laboratory manual (2nd ed.). Montreal, Саnada: World Federation of Hemophilia (WFH). 2010: 144 p.
  30. Krasivska VV, Stasyshyn OV, Novak VL. Laboratory diagnosis of hemorrhagic diseases: Study guide. K.:KVSH. 2021; 100 p.
  31. Chitlur M, Rivard GE, Lillicrap D, et al. Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 2014;12:103-6.doi.org/10.1111/jth.12458
  32. Perry DJ, Fitzmaurice DA, Kitchen S. et al. Point-of-care testing in haemostasis. British Journal of Haematology. 2010;150:501-14.doi.org/10.1111/j.1365-2141.2010.08223.x
  33. Pathirana S, Wong G, Williams P, Yang K, Kershaw G, Dunkley S, et al. The effects of haemodilution with albumin on coagulation in vitro as assessed by rotational thromboelastometry. Anaesth Intens Care. (2015) 43:187-92.doi.org/10.1177/0310057X1504300207
  34. Adamik KN, Yozova ID. Colloids Yes or No? - a «Gretchen Question» Answered. Front Vet Sci. 2021 Jul 2:8:624049.doi.org/10.3389/fvets.2021.624049


Програмування - Roman.im | QR-Code Generator